66 related articles for article (PubMed ID: 12578701)
1. [Therapeutic Effects on Chemotherapy-Induced Granulocytopenia in Hematologic Malignacies, a Comparison Between Lishengsu and Filgrastim].
Huang H; Chen F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Jun; 8(2):122-125. PubMed ID: 12578701
[TBL] [Abstract][Full Text] [Related]
2. [Curative Effect of Lishengsu on Leukopenia and Infection after Chemotherapy in Tumor Patients].
Yang Y; Zhang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Jun; 8(2):126-128. PubMed ID: 12578702
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic Effects of Lishengsu on Chemotherapy Induced Leukopenia in Patients with Malignant Tumor].
Xu Z; Xu KY; Liu T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Mar; 9(1):67-69. PubMed ID: 12578649
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
[TBL] [Abstract][Full Text] [Related]
5. [Curative effect of rhG-CSF on leukopenia induced by chemoradiotherapy in 140 cases of malignant tumors].
Zhang XD; Wu ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):103-4. PubMed ID: 14989782
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
7. [Lishengsu promotes the recovery of chemotherapy-induced leukopenia in patients with malignant tumors].
Li ZJ; Mo ZY; Xiong K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):85-6. PubMed ID: 12513846
[TBL] [Abstract][Full Text] [Related]
8. [Clinical application of Lishengsu for treatment of leukopenia induced by chemotherapy].
Jiang NX; Zhang Q; Zhang BH; Zhang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):96-8. PubMed ID: 12667300
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy.
Kim IH; Park SK; Suh OK; Oh JM
Curr Med Res Opin; 2003; 19(8):753-9. PubMed ID: 14687447
[TBL] [Abstract][Full Text] [Related]
10. [A brief report on effect of rhG-CSF in treating leukopenia after radio-and chemo-therapy of patients with breast cancer].
Wang TJ; Liu LL; Cheng GH; Liu XL; Qu YQ; Wu ZF; Zhang CF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):381-2. PubMed ID: 15228673
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study of rhG-CSF in accelerating hematological recovery following autologous hematopoietic stem cells transplantation].
Yang JL; Shi YK; He XH; Zhou SY; Zhou AP; Han XH; Liu P; Zhang CG; Ai B
Ai Zheng; 2003 Aug; 22(8):785-9. PubMed ID: 12917020
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
14. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
Milano-Bausset E; Gaudart J; Rome A; Coze C; Gentet JC; Padovani L; Lacarelle B; André N
Clin Ther; 2009; 31 Pt 2():2388-95. PubMed ID: 20110048
[TBL] [Abstract][Full Text] [Related]
15. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
Suzue T; Takaue Y; Watanabe A; Kawano Y; Watanabe T; Abe T; Kuroda Y; Matsushita T; Kikuta A; Iwai A
Exp Hematol; 1994 Nov; 22(12):1197-202. PubMed ID: 7523170
[TBL] [Abstract][Full Text] [Related]
16. A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancer.
Mehdi SA; Perry MC; Herndon JE; Crawford J; Young R; Graziano SL
J Interferon Cytokine Res; 1998 Aug; 18(8):623-7. PubMed ID: 9726444
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
Smith GM; Child JA; Cullen MH; Bailey NP; Woodruffe CM; Fletcher J; Earl H; Barnard D
Hematol Oncol; 1996 Dec; 14(4):193-201. PubMed ID: 9267465
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
